BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 18544264)

  • 21. Local excision for more advanced rectal tumors.
    Borschitz T; Kneist W; Gockel I; Junginger T
    Acta Oncol; 2008; 47(6):1140-7. PubMed ID: 18607868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rectal carcinoma. Optimizing treatment by neoadjuvant and adjuvant therapy?].
    Fasolini F
    Zentralbl Chir; 1999; 124(5):441-5. PubMed ID: 10420532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is radiotherapy for rectal cancer indicated if surgery is optimized?
    Edwards DP; Mortensen NJ
    Eur J Surg Oncol; 2001 Aug; 27(5):442-5. PubMed ID: 11504512
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
    Gollins S
    Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rectal carcinoma--oncologically adequate resection].
    Simon D
    Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will we ever succeed in resolving the adjuvant treatment dilemma in rectal cancer?
    Petrelli NJ
    J Surg Oncol; 2003 Feb; 82(2):79-83. PubMed ID: 12561061
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision.
    Colquhoun P; Wexner SD; Cohen A
    J Surg Oncol; 2003 Jul; 83(3):133-9. PubMed ID: 12827680
    [No Abstract]   [Full Text] [Related]  

  • 28. Preoperative chemoradiotherapy in locally advanced rectal cancer: Ramathibodi experience.
    Sirachainan E; Sumboonnanonda K; Dangprasert S; Panvichian R; Sirisinha T; Dhanachai M; Pairachvet V; Kraiphibul P; Ratanatharathorn V
    J Med Assoc Thai; 2005 Feb; 88(2):162-7. PubMed ID: 15962665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is local excision and chemoradiation an acceptable alternative in the treatment of early rectal cancer?
    Spiliotis JD; Datsis AC
    J BUON; 2007; 12(1):23-7. PubMed ID: 17436397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-operative radiotherapy in rectal cancer: evaluation of irradiation effects on cellular undifferentiation and its influence on prognosis.
    Reis Neto JA; Quilici FA; Cordeiro F; Ciquini S; Reis JA
    Hepatogastroenterology; 1999; 46(29):2825-30. PubMed ID: 10576354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant therapy and mini-invasive total mesorectal excision for rectal cancer: feasibility and outcome analysis from a single institution prospectively collected data base.
    Grosso F; MandalĂ  M; Maglione V; Berretta L; Mariani N; Rossi M; Piovano PL; Drago D; Summa M; Franzone P; Musante F; Spinoglio G
    Tumori; 2012 Nov; 98(6):689-95. PubMed ID: 23389353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.
    Vironen J; Juhola M; Kairaluoma M; Jantunen I; Kellokumpu I
    Int J Colorectal Dis; 2005 Sep; 20(5):440-5. PubMed ID: 15856263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.
    Perez RO; Habr-Gama A; Nishida Arazawa ST; Rawet V; Coelho Siqueira SA; Kiss DR; Gama-Rodrigues JJ
    Int J Colorectal Dis; 2005 Sep; 20(5):434-9. PubMed ID: 15759124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rational principles of neo-adjuvant therapy for rectal cancer.
    Tonelli F; Asteria CR; Marcucci T
    Acta Biomed; 2003; 74 Suppl 2():96-102. PubMed ID: 15055045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
    Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary treatment of resectable rectal cancer.
    Ayala DN; Russo SM; Blackstock AW
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging.
    Larsen SG; Wiig JN; Emblemsvaag HL; Grøholt KK; Hole KH; Bentsen A; Dueland S; Vetrhus T; Giercksky KE
    Colorectal Dis; 2009 Sep; 11(7):759-67. PubMed ID: 18662240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer.
    Miller ED; Robb BW; Cummings OW; Johnstone PA
    Dis Colon Rectum; 2012 Sep; 55(9):1002-7. PubMed ID: 22874609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting anastomotic complications following anterior resection in rectal cancer.
    Lyall A; Mc Adam TK; Townend J; Loudon MA
    Colorectal Dis; 2007 Nov; 9(9):801-7. PubMed ID: 17931170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.